Loading organizations...
Loading organizations...
Biopharmaceutical company developing tumor immunotherapy and precision drug
CStone Pharmaceuticals has raised $405.7M across 2 funding rounds.
CStone Pharmaceuticals has raised $405.7M in total across 2 funding rounds.
CStone Pharmaceuticals has raised $405.7M in total across 2 funding rounds.
CStone Pharmaceuticals's investors include GIC, 3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, Terra Magnum Capital Partners.
CStone Pharmaceuticals has raised $405.7M across 2 funding rounds. Most recently, it raised $259.2M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 9, 2018 | $259.2M Series B | GIC | 3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital |
| Jul 4, 2016 | $146.5M Series A | Boyu Capital, WuXi Healthcare Ventures |